We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
SCIEX Logo

SCIEX

SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.

Latest SCIEX Content

Scientist handling a pipette over a petri dish in a lab, representing cell line research and experimentation.
Article

Cell Lines: Current Challenges in Cell Line Development for Therapeutics

This article explores some of the challenges in developing cell lines for therapeutics, such as cell line stability, and how they are being addressed.
One in-focus strand of RNA with a background of blurred strands.
Article

A Bright Future for RNA Therapeutics

RNA therapeutics promise rapid, personalized and flexible treatments against multiple diseases. In this article, we will explore whether RNA therapeutics can realize their full potential.
Multichannel pipette dispensing red liquid into tubes under bright neon lighting, creating a futuristic lab atmosphere.
How To Guide

Streamline Pharmaceutical Quantitation With Trusted LC-MS/MS Solutions

This guide offers a comprehensive overview of advanced LC-MS/MS solutions designed to simplify and accelerate your processes.
Illustration of two therapeutic antibodies (blue) binding to receptors on a cell membrane (orange), blocking cellular pathways.
Webinar

Monitor Protein Therapeutic Color Changes With LC-MS

On-Demand
This webinar explores the implementation of a liquid chromatography mass spectrometry (LC-MS) workflow for peptide mapping to investigate and track these PTMs.
BioPhase 8800 system: Multi-assay, multi-capillary electrophoresis system
Product
Advertisement

BioPhase 8800 system: Multi-assay, multi-capillary electrophoresis system

Access this collection of resources to explore how capillary electrophoresis (CE) and mass spectrometry (MS) solutions can help you ensure the quality, safety and efficacy of your new drug candidates.
Flat vector textured illustration representing male and female scientist and concept of increasing pharmacogenomics researches.
Compendium

Achieving Cell and Gene Therapy Excellence

This compendium explores analytical advancements in cell and gene therapy, highlighting the latest tools and strategies for ensuring therapeutic quality.
Unlocking the Power of Echo® MS+ System for Drug Discovery Assays
Video

Unlocking the Power of Echo® MS+ System for Drug Discovery Assays

When the quantity of samples is your challenge, breakthrough with Echo® MS+ systems. The Echo® MS+ system gives you high-quality data, analytical flexibility and high sample throughput so you can make the right decisions, today.
Accelerating drug discovery with acoustic ejection mass spectrometry
Product
Advertisement

Echo® MS+ System

When the quantity of samples is your challenge, breakthrough with the Echo® MS+ system.
Spirals of protein with molecular structure "falling" out
Industry Insight

Enhancing Biopharmaceutical Efficiency: Intact-Level PTM Identification and Charge Variant Analysis

In this interview, Technology Networks spoke with Dr. Jingwen Ding, senior applications scientist at SCIEX, to understand how charge variant analysis and advanced technologies can enhance biopharmaceutical workflows.
The image shows multiple colorful, large, complex molecular structures floating in a space with a gradient background.
Webinar

Removing the Bottlenecks from Glycosylation Analysis

On-Demand
Join our free webinar to explore advanced glycan analysis using CE-MS and icIEF-MS. Learn rapid screening, in-depth characterization and strategies for ensuring lot-to-lot consistency in glycosylation profiles during protein therapeutics development.
Advertisement